There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is
characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells …

Available evidence suggests that the incidence of leukemia and lymphoma tends to be
higher in highly developed regions of the world and among Whites in the United States …

Relapsed and refractory acute lymphoblastic leukemia (ALL) remains difficult to treat, with
minimal improvement in outcomes seen in more than 2 decades despite advances in upfront …

Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …

Background Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has shown
remarkable activity in patients with refractory or relapsed acute lymphocytic leukaemia …

Five-year survival has increased for many hematologic malignancies in the 21st century.
However, whether this has translated into greater long-term survival is unknown. Here, we …

Racial and ethnic disparities in patients with solid malignancies have been well
documented. Less is known about these disparities in patients with hematologic …

There has been an increase in volume as well as an improvement in overall survival (OS)
after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if …

Background Homoharringtonine-based induction regimens have been widely used in China
for patients with acute myeloid leukaemia. However, their efficacy has not been tested in a …